Skip to main content

Table 1 Patient demographic and clinical characteristics

From: Diffusion-weighted imaging for identifying patients at high risk of tumor recurrence following liver transplantation

VariableN = 97
Age (years) at transplantation55.6 ± 8.3 (34–70)
Gender
 Male65 (67)
 Female32 (33)
Underlying liver disease
 HBV45 (46)
 HCV38 (39)
 HBV, HCV coinfection5 (5)
 Non-B, Non-C9 (10)
MELD score10.2 ± 3.8 (6–23)
Alpha-fetoprotein level (ng/mL)15.69 ± 22.82 (3–153)
Pretransplant treatment
 Yes82 (84)
  Hepatectomy5
  Locoregional therapy (RFA, TACE)57
  Hepatectomy + Locoregional therapy20
 No15 (16)
Tumor downstaging5 (5)
Tumor recurrence
 Yes16 (17)
 No81 (83)
  1. Data are presented as numbers (%) or mean ± SD (range)